You just read:

Veloxis Announces Scientific Publication of Phase II Study Demonstrating Conversion from Twice-Daily Tacrolimus to Once-Daily Envarsus® in Liver Transplant Patients

News provided by

Veloxis Pharmaceuticals

Apr 28, 2014, 11:00 ET